DE60041637D1 - Augenbehandlung unter verwendung von cyclosporin a derivaten - Google Patents

Augenbehandlung unter verwendung von cyclosporin a derivaten

Info

Publication number
DE60041637D1
DE60041637D1 DE60041637T DE60041637T DE60041637D1 DE 60041637 D1 DE60041637 D1 DE 60041637D1 DE 60041637 T DE60041637 T DE 60041637T DE 60041637 T DE60041637 T DE 60041637T DE 60041637 D1 DE60041637 D1 DE 60041637D1
Authority
DE
Germany
Prior art keywords
eye
cyclosporine
derivatives
derivative
eye treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60041637T
Other languages
English (en)
Inventor
Michael E Garst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of DE60041637D1 publication Critical patent/DE60041637D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
DE60041637T 1999-04-13 2000-04-04 Augenbehandlung unter verwendung von cyclosporin a derivaten Expired - Lifetime DE60041637D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/290,833 US6254860B1 (en) 1999-04-13 1999-04-13 Ocular treatment using cyclosporin-A derivatives
PCT/US2000/008877 WO2000061168A1 (en) 1999-04-13 2000-04-04 Ocular treatment using cyclosporin-a derivatives

Publications (1)

Publication Number Publication Date
DE60041637D1 true DE60041637D1 (de) 2009-04-09

Family

ID=23117740

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60041637T Expired - Lifetime DE60041637D1 (de) 1999-04-13 2000-04-04 Augenbehandlung unter verwendung von cyclosporin a derivaten

Country Status (11)

Country Link
US (2) US6254860B1 (de)
EP (1) EP1169050B1 (de)
JP (1) JP4711516B2 (de)
AT (1) ATE423566T1 (de)
AU (1) AU759753B2 (de)
CA (1) CA2369457C (de)
DE (1) DE60041637D1 (de)
DK (1) DK1169050T3 (de)
ES (1) ES2319853T3 (de)
NZ (1) NZ514105A (de)
WO (1) WO2000061168A1 (de)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6254860B1 (en) * 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
PT1393277E (pt) 2001-05-21 2006-09-29 Alcon Inc Utilizacao de inibidores de nf-kb para tratar disturbios de olho seco
US6872382B1 (en) 2001-05-21 2005-03-29 Alcon, Inc. Use of selective PDE IV inhibitors to treat dry eye disorders
US7112588B2 (en) 2001-05-21 2006-09-26 Alcon, Inc. Use of proteasome inhibitors to treat dry eye disorders
CA2447909C (en) 2001-05-21 2011-04-05 Alcon, Inc. Use of proteasome inhibitors to treat dry eye disorders
US6645994B1 (en) 2001-06-01 2003-11-11 Alcon, Inc. Method of treating dry eye disorders
US7351404B2 (en) 2002-02-04 2008-04-01 Allergan, Inc. Method of enhancing hair growth
US9216183B2 (en) 2002-02-04 2015-12-22 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US8758733B2 (en) 2002-02-04 2014-06-24 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
WO2004027027A2 (en) * 2002-09-18 2004-04-01 Trustees Of The University Of Pennsylvania Method of inhibiting choroidal neovascularization
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
US7083802B2 (en) * 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
AU2004274026A1 (en) 2003-09-18 2005-03-31 Macusight, Inc. Transscleral delivery
US7083803B2 (en) * 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
US7087237B2 (en) * 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
US20050181018A1 (en) * 2003-09-19 2005-08-18 Peyman Gholam A. Ocular drug delivery
US20050232972A1 (en) * 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
US20050261243A1 (en) * 2004-04-21 2005-11-24 Peyman Gholam A Antiprostaglandins for the treatment of ocular pathologies
US7196161B2 (en) * 2004-10-01 2007-03-27 Scynexis Inc. 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
AU2005292162B2 (en) * 2004-10-01 2011-11-10 Scynexis, Inc 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
US7151085B2 (en) * 2004-11-15 2006-12-19 Allergan, Inc. Therapeutic methods using cyclosporine components
US7135455B2 (en) * 2004-11-15 2006-11-14 Allergan, Inc Methods for the therapeutic use of cyclosporine components
ES2564194T3 (es) 2005-02-09 2016-03-18 Santen Pharmaceutical Co., Ltd. Formulaciones líquidas para el tratamiento de enfermedades o dolencias
US8663639B2 (en) 2005-02-09 2014-03-04 Santen Pharmaceutical Co., Ltd. Formulations for treating ocular diseases and conditions
US20070015691A1 (en) 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7276476B2 (en) * 2005-07-13 2007-10-02 Allergan, Inc. Cyclosporin compositions
US7288520B2 (en) * 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US20070015693A1 (en) * 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7297679B2 (en) * 2005-07-13 2007-11-20 Allergan, Inc. Cyclosporin compositions
US7202209B2 (en) 2005-07-13 2007-04-10 Allergan, Inc. Cyclosporin compositions
US20080262415A1 (en) * 2005-07-18 2008-10-23 Peyman Gholam A Enhanced wound healing
US7501393B2 (en) 2005-07-27 2009-03-10 Allergan, Inc. Pharmaceutical compositions comprising cyclosporins
DE602006020152D1 (de) * 2005-09-30 2011-03-31 Scynexis Inc Arylalkyl- und heteroarylalkyl-derivate von cyclosporin a bei der behandlung und vorbeugung einer virusinfektion
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
AU2006304143A1 (en) 2005-10-14 2007-04-26 Allergan, Inc. Prevention and treatment of drug-associated ocular side effects with a cyclosporin
US7745400B2 (en) * 2005-10-14 2010-06-29 Gregg Feinerman Prevention and treatment of ocular side effects with a cyclosporin
EP1956906A4 (de) 2005-11-09 2009-12-30 Combinatorx Inc Verfahren, zusammensetzungen und kits für die behandlung von medizinischen beschwerden
KR20140093764A (ko) 2006-02-09 2014-07-28 산텐 세이야꾸 가부시키가이샤 안정한 제제와 그 제조 및 사용 방법
WO2007095486A1 (en) * 2006-02-13 2007-08-23 Allergan, Inc. Methods of treating blepharospasm using cyclosporine components
US11311477B2 (en) 2006-03-07 2022-04-26 Sgn Nanopharma Inc. Ophthalmic preparations
US10137083B2 (en) 2006-03-07 2018-11-27 SGN Nanopharma Inc Ophthalmic preparations
DK2001466T3 (en) 2006-03-23 2016-02-29 Santen Pharmaceutical Co Ltd LOW-DOSAGE RAPAMYCINE FOR TREATMENT OF VASCULAR PERMEABILITY-RELATED DISEASES
DK2023918T3 (da) * 2006-05-19 2011-04-26 Scynexis Inc Cyclosporiner til behandlingen og forebyggelse af okulære lidelser
JP2009539292A (ja) * 2006-06-02 2009-11-12 ぺリション、クロード、アニー 活性電子の管理
WO2008069917A2 (en) * 2006-11-20 2008-06-12 Scynexis, Inc. Novel cyclic peptides
AU2008219600A1 (en) * 2007-02-28 2008-09-04 Aciex Therapeutics, Inc. Methods and compositions for normalizing meibomian gland secretions
US20080255038A1 (en) * 2007-04-11 2008-10-16 Samuel Earl Hopkins Pharmaceutical compositions
US20080265343A1 (en) * 2007-04-26 2008-10-30 International Business Machines Corporation Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
CA2686234A1 (en) * 2007-05-04 2008-11-13 Allergan, Inc. Use of cyclosporines in the treatment of patients with intraocular lenses
CN101918019B (zh) 2007-10-08 2014-11-26 奥里尼亚制药有限公司 包含钙调神经磷酸酶抑制剂或mTOR抑制剂的眼科组合物
CN102149402B (zh) * 2008-07-10 2014-07-09 阿勒根公司 用于治疗眼睛和皮肤的疾病和病症的环孢菌素衍生物
US20100204335A1 (en) * 2008-12-01 2010-08-12 Allergan, Inc. Kit and composition for eyelash growth
JP5780969B2 (ja) * 2008-12-31 2015-09-16 サイネクシス，インコーポレーテッド シクロスポリンａの誘導体
EA201190089A1 (ru) 2009-01-08 2012-02-28 Аллерган, Инк. Композиции для усиления роста ногтей
US20100229735A1 (en) * 2009-03-13 2010-09-16 Olaf Industries, Inc. Coil Spring Compactor
US20110009339A1 (en) 2009-04-14 2011-01-13 Allergan, Inc Method of treating blurred vision and other conditions of the eye with cyclosporin compositions
WO2010127301A1 (en) * 2009-05-01 2010-11-04 Allergan, Inc. Method of treating allergic conjunctivitis with cyclosporin compositions
US20100305047A1 (en) * 2009-05-27 2010-12-02 Allergan, Inc. Cyclosporin derivatives for enhancing the growth of hair
WO2010138423A1 (en) * 2009-05-27 2010-12-02 Allergan, Inc. Cyclosporin derivatives for treating inflammatory diseases and conditions
MX338355B (es) 2009-06-09 2016-04-13 Aurinia Pharmaceuticals Inc Sistemas de suministro de farmaco topico para uso oftalmico.
PL2498783T3 (pl) 2009-11-09 2019-04-30 Allergan Inc Kompozycje i sposoby stymulowania wzrostu włosów
US9149484B2 (en) 2009-11-09 2015-10-06 Allergan, Inc. Compositions and methods for stimulating hair growth
CN103328497A (zh) * 2010-10-12 2013-09-25 阿勒根公司 环孢菌素类似物
JP5805773B2 (ja) * 2010-10-12 2015-11-10 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ シクロスポリンアナログ
US20120129789A1 (en) 2010-11-18 2012-05-24 Steven Yoelin Compositions and methods for hair growth
US8859616B2 (en) 2011-01-21 2014-10-14 Allergan, Inc. Compounds and methods for enhancing hair growth
CA2836946C (en) 2011-05-27 2017-08-01 Allergan, Inc. A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof
JP2014528447A (ja) 2011-10-05 2014-10-27 アラーガン インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ 爪の健康状態を増進するための組成物
US20130089508A1 (en) 2011-10-05 2013-04-11 Allergan, Inc. Compositions for enhancing nail health
US8796222B2 (en) 2011-11-15 2014-08-05 Allergan, Inc. Suspensions of cyclosporin A form 2
RU2630970C2 (ru) 2011-11-15 2017-09-15 Аллерган, Инк. Автоклавируемые взвеси циклоспорина а формы 2
FR2988297B1 (fr) * 2012-03-22 2014-03-28 Thea Lab Solution ophtalmique aqueuse a base de ciclosporine a sans conservateur
US20150164765A1 (en) 2012-05-17 2015-06-18 Steven G. Yoelin Compositions and methods for hair growth
US9266927B2 (en) 2012-06-01 2016-02-23 Allergan, Inc. Cyclosporin A analogs
US9878000B2 (en) 2012-06-20 2018-01-30 University Of Waterloo Mucoadhesive nanoparticle composition comprising immunosuppresant and methods of use thereof
JP6275707B2 (ja) 2012-06-20 2018-02-07 フランク・グー 粘膜付着性ナノ粒子送達系
EP2964269A1 (de) 2013-03-08 2016-01-13 Allergan, Inc. Cyclosporin-a-steroid-konjugate
RU2768489C2 (ru) 2013-03-14 2022-03-24 Паноптика, Инк. Офтальмологические составы для доставки лекарственных средств к заднему сегменту глаза
US10149610B2 (en) * 2014-04-25 2018-12-11 Carl Zeiss Meditec, Inc. Methods and systems for automatic detection and classification of ocular inflammation
WO2016112321A1 (en) 2015-01-08 2016-07-14 Allergan, Inc. Cyclosporin derivatives wherein the mebmt sidechain has been cyclized
CN107106325B (zh) 2015-01-12 2021-05-25 科达莱昂治疗公司 微滴递送设备和方法
AU2016246060B2 (en) 2015-04-10 2020-10-22 Bausch + Lomb Ireland Limited Piezoelectric dispenser with replaceable ampoule
US9820954B2 (en) 2015-08-19 2017-11-21 Jenivision Inc. Quantitative peri-orbital application of ophthalmology drugs
CA3039106A1 (en) 2017-01-20 2018-07-26 Kedalion Therapeutics, Inc. Piezoelectric fluid dispenser
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis
JP7436363B2 (ja) 2017-12-08 2024-02-21 ノバルティス アーゲー 流体送達アライメントシステム
US11679028B2 (en) 2019-03-06 2023-06-20 Novartis Ag Multi-dose ocular fluid delivery system
US10993944B2 (en) 2019-08-07 2021-05-04 Aneira Pharma, Inc. Methods and compositions for the treatment of hair loss
WO2021212033A1 (en) 2020-04-17 2021-10-21 Kedallon Therapeutics, Inc. Hydrodynamically actuated preservative free dispensing system
US11938057B2 (en) 2020-04-17 2024-03-26 Bausch + Lomb Ireland Limited Hydrodynamically actuated preservative free dispensing system
CN116473017B (zh) * 2023-03-22 2024-01-05 首都医科大学附属北京同仁医院 基于小鼠泪腺诱导的干燥综合征小鼠模型的造模方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649047A (en) 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
KR920003601B1 (ko) 1987-09-03 1992-05-04 유니버시티 어브 죠지아 리서취 화운데이션 인코포레이티드 점안 싸이클로스포린(cyclosporin)의 조성물
US4839342A (en) 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
FR2638089A1 (fr) * 1988-10-26 1990-04-27 Sandoz Sa Nouvelles compositions ophtalmiques a base d'une cyclosporine
FR2757522B1 (fr) 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2757520B1 (fr) 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Derive de cyclosporine, sa preparation et les compositions pharmaceutiques qui le contiennent
FR2757521B1 (fr) 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
US6254860B1 (en) * 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives

Also Published As

Publication number Publication date
US6254860B1 (en) 2001-07-03
US6350442B2 (en) 2002-02-26
CA2369457A1 (en) 2000-10-19
AU759753B2 (en) 2003-05-01
NZ514105A (en) 2005-01-28
ES2319853T3 (es) 2009-05-14
JP4711516B2 (ja) 2011-06-29
EP1169050B1 (de) 2009-02-25
ATE423566T1 (de) 2009-03-15
WO2000061168A1 (en) 2000-10-19
DK1169050T3 (da) 2009-04-14
JP2002541207A (ja) 2002-12-03
CA2369457C (en) 2010-08-10
US20010036449A1 (en) 2001-11-01
AU4193500A (en) 2000-11-14
EP1169050A1 (de) 2002-01-09

Similar Documents

Publication Publication Date Title
DE60041637D1 (de) Augenbehandlung unter verwendung von cyclosporin a derivaten
AU784017B2 (en) Solutions containing epinastine
DE69802688T2 (de) Stabilisierung von säureempfindluchen benzimidazolen unter verwendung von aminosäure/cyclodextrin kombinationen
EP1007013A4 (de) Parenterales pimaricin zur behandlung von systemischen infektionen
MX9707453A (es) Derivados de quinazolina.
ECSP066314A (es) Derivados piridilo y su uso como agentes terapéuticos
EE04239B1 (et) Hüdroksüülamiini derivaadid, mis on kasutatavad molekulaarse seostusvalgu moodustumise suurendamiseks, ja nende valmistamine
WO2002038171A3 (en) METHODS FOR TREATING DISEASES CAUSED BY DEFICIENCIES OF α-L-IDURONIDASE
DE69922676D1 (de) N-aralkylaminotetraline als neuropeptid-y-y5-rezeptorliganden
EA200500583A1 (ru) Ингибиторы белка-регулятора трансмембранной проводимости при муковисцидозе и их применение
MX9701229A (es) Antifungicos de tetrahidrofurano.
PT1137430E (pt) Terapeutica para a supressao dos ruidos do ressonar
NO990433L (no) Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet
HUP0004282A2 (hu) 2-Halogén-6-0-szubsztituált ketolidszármazékok
WO1999063978A3 (en) Methods of treating microbial infection and therapeutic formulations therefor
ATE344249T1 (de) Pyrazinone, diese verbindungen enthaltende zusammenstellungen
NO20013414D0 (no) Ny anvendelse av melagatran
WO2006031706A3 (en) Betulinol derivatives as anti-hiv agents
BR0211970A (pt) Uso de bibn4096 em combinação com outras drogas antienxaqueca para o tratamento de enxaqueca
TW200503709A (en) Itching treating agent containing piperidine derivative as active ingredient
DE10299023I2 (de) Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff
DK0671909T3 (da) Syndecanstimulering af cellulær differentiering
MY133222A (en) Method of treating glaucoma and ischemic retinopathy
WO2001079193A3 (en) Substituted hydrazinyl heteroaromatic inhibitors of thrombin
MX9604692A (es) Derivados de quinoxalina para el tratamiento de tinnitus.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition